Press Room

News / Mar 04, 2020

Hovione scholarship program supports four students from IST

Hovione renews the scholarship of three students and extended the support to one student

Hovione scholarship program supports four students from IST | Hovione
The students with Hélder Delgado, Sustainability Specialist at Hovione.

Hovione renews the scholarship of three students and extends the support to one student, all from the Instituto Superior Técnico (IST). The ceremony took place on Tuesday, 3rd March. Hovione’s scholarship program – “Hovione Solidária na Educação” – will continue to support Ricardo Dias, Beatriz Colaço and Ana Oliveira (Chemical engineering students) and will extend the support to Mariana Carreira Bento (Biomedical engineering student).

“These scholarships are a way of expressing our gratitude to the universities that produce the most employable graduates and also a way of supporting students with outstanding academic merit who need financial aid”. Hélder Delgado gave an example of a former scholarship recipient from Técnico who is currently working at Hovione and expressed his wish that what has happened before may happen again with these students. “We want to turn this support into useful relationships between our company and students”.

 

Read the entire article on IST's website

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025